RNase T2 in inflammation and cancer: Immunological and biological views

L Wu, Y Xu, H Zhao, Y Li - Frontiers in Immunology, 2020 - frontiersin.org
The RNase T2 family consists of evolutionarily conserved endonucleases that express in
many different species, including animals, plants, protozoans, bacteria, and viruses. The …

Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene

F Acquati, L Mortara, A De Vito, D Baci… - Frontiers in …, 2019 - frontiersin.org
The link between cancer development or progression and immune system dysregulation
has long been established. Virtually every cell type belonging to both the innate and …

Proteome-wide characterization of the RNA-binding protein RALY-interactome using the in vivo-biotinylation-pulldown-quant (iBioPQ) approach

S Tenzer, A Moro, J Kuharev, AC Francis… - Journal of proteome …, 2013 - ACS Publications
RALY is a member of the heterogeneous nuclear ribonucleoproteins, a family of RNA-
binding proteins generally involved in many processes of mRNA metabolism. No …

tRNAArg-derived fragments can serve as arginine donors for protein arginylation

I Avcilar-Kucukgoze, H Gamper, C Polte, Z Ignatova… - Cell chemical …, 2020 - cell.com
Arginyltransferase ATE1 mediates posttranslational arginylation and plays key roles in
multiple physiological processes. ATE1 utilizes arginyl (Arg)-tRNA Arg as the donor of Arg …

HIF2α‐induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma

Y Quan, J Dai, S Zhou, L Zhao, L Jin, Y Long… - FEBS Open …, 2023 - Wiley Online Library
Clear cell renal cell carcinoma (ccRCC), the most common malignant subtype of renal cell
carcinoma, is characterized by the accumulation of lipid droplets in the cytoplasm. RNASET2 …

The potential role of the t2 ribonucleases in tme-based cancer therapy

P Campomenosi, L Mortara, B Bassani, R Valli, G Porta… - Biomedicines, 2023 - mdpi.com
In recent years, there has been a growing interest in developing innovative anticancer
therapies targeting the tumor microenvironment (TME). The TME is a complex and dynamic …

Human RNASET2: a highly pleiotropic and evolutionary conserved tumor suppressor gene involved in the control of ovarian cancer pathogenesis

A Bruno, DM Noonan, R Valli, G Porta… - International Journal of …, 2022 - mdpi.com
Ovarian cancer represents one of the most malignant gynecological cancers worldwide, with
an overall 5-year survival rate, being locked in the 25–30% range in the last decade. Cancer …

Identification and prioritization of PET neuroimaging targets for microglial phenotypes associated with microglial activity in Alzheimer's disease

ND Bartolo, N Mortimer, MA Manter… - ACS Chemical …, 2022 - ACS Publications
Activation of microglial cells accompanies the progression of many neurodegenerative
disorders, including Alzheimer's disease (AD). Development of molecular imaging tools …

Structure and activity of the only human RNase T2

A Thorn, R Steinfeld, M Ziegenbein… - Nucleic acids …, 2012 - academic.oup.com
Mutations in the gene of human RNase T2 are associated with white matter disease of the
human brain. Although brain abnormalities (bilateral temporal lobe cysts and multifocal …

RNASET2 is required for ROS propagation during oxidative stress-mediated cell death

G Caputa, S Zhao, AEG Criado, DS Ory… - Cell Death & …, 2016 - nature.com
RNASET2 is a ubiquitously expressed acidic ribonuclease that has been implicated in
diverse pathophysiological processes including tumorigeneis, vitiligo, asthenozoospermia …